About This Research Desk

What AJW Peptides is

AJW Peptides is an independent editorial reference desk covering the published science on two research peptides studied for the growth hormone axis: CJC-1295 and sermorelin. The site exists to make a dense, often overstated, and sometimes factually muddled literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches.

The frame is the 'CJC-1295 and the GH-axis stack' angle: two GHRH analogs that bind the same receptor and trigger the same downstream cascade but differ dramatically in half-life, engineering, and regulatory history. Sermorelin is the natural fragment and the compounded drug; CJC-1295 is the engineered long-duration analog with no approved use. Reading them together captures the full spectrum of this compound class — from the short-lived, feedback-regulated signal to the multi-day sustained elevation — and puts the tradeoffs in context.

Each compound has its own page. A comparison page lines them up on the dimensions that matter: class, evidence, regulatory standing, key cautions. A single references list aggregates every cited source across all pages.

Editorial method

Every claim on this desk is traceable to a citation. Sources are limited to peer-reviewed journal articles, regulatory documents (FDA briefing materials), and published editorials and reviews in indexed journals. Each citation is numbered and resolves to the shared references list with a DOI or PubMed link.

When the evidence is preclinical, we say so: we name the species, note the study size, and flag when a result comes from a single research group or a single small trial. When safety concerns exist in the literature, we report them directly — including when those concerns come from regulatory bodies. We do not filter out unfavorable findings to make a compound look better, and we do not extrapolate from pediatric or diseased-population data to healthy-adult efficacy claims.

Community anecdotal reports are presented on compound pages where the source material captured them, clearly labeled as 'anecdotal, not clinical evidence.' They are included because they describe effects that people actually report and because honest coverage of what users experience is part of the record. They are never given the same epistemic weight as controlled trials.

This desk has no commercial relationship with any peptide supplier, compounding pharmacy, telehealth provider, or wellness clinic. No products are sold here. No affiliate links are placed. No compensation has been received for any content.

What this desk is not

AJW Peptides is not a clinic, not a vendor, not a source of medical advice, and not a dosing reference. It does not tell anyone what to use, how much to use, when to use it, or whether it is appropriate for their situation. Those are medical questions that require a licensed clinician with knowledge of the individual patient.

If the research described here is relevant to a clinical or personal decision, the appropriate next step is a conversation with a physician — not a closer reading of this site. Research peptides are not approved medicines (with the limited exception of sermorelin's prior pediatric approval, now commercially withdrawn), are not dietary supplements, and are not equivalent to prescribed treatments. The 'research use only' framing under which these compounds are sold reflects a real regulatory and evidentiary gap, not a legal technicality to work around.

Contact: editorial@ajwpeptides.com